Access to gender-affirming hormones during adolescence and mental health outcomes among transgender adults
Authors:
Top Cited Papers
Open Access
- 12 January 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (1) , e0261039
Abstract
Objective: To examine associations between recalled access to gender-affirming hormones (GAH) during adolescence and mental health outcomes among transgender adults in the U.S. Methods: We conducted a secondary analysis of the 2015 U.S. Transgender Survey, a cross-sectional non-probability sample of 27,715 transgender adults in the U.S. Using multivariable logistic regression adjusting for potential confounders, we examined associations between access to GAH during early adolescence (age 14–15), late adolescence (age 16–17), or adulthood (age ≥18) and adult mental health outcomes, with participants who desired but never accessed GAH as the reference group. Results: 21,598 participants (77.9%) reported ever desiring GAH. Of these, 8,860 (41.0%) never accessed GAH, 119 (0.6%) accessed GAH in early adolescence, 362 (1.7%) accessed GAH in late adolescence, and 12,257 (56.8%) accessed GAH in adulthood. After adjusting for potential confounders, accessing GAH during early adolescence (aOR = 0.4, 95% CI = 0.2–0.6, p < .0001), late adolescence (aOR = 0.5, 95% CI = 0.4–0.7, p < .0001), or adulthood (aOR = 0.8, 95% CI = 0.7–0.8, p < .0001) was associated with lower odds of past-year suicidal ideation when compared to desiring but never accessing GAH. In post hoc analyses, access to GAH during adolescence (ages 14–17) was associated with lower odds of past-year suicidal ideation (aOR = 0.7, 95% CI = 0.6–0.9, p = .0007) when compared to accessing GAH during adulthood. Conclusion: Access to GAH during adolescence and adulthood is associated with favorable mental health outcomes compared to desiring but not accessing GAH.Keywords
Funding Information
- the American Academy of Child and Adolescent Psychiatry (Pilot Research Award for General Psychiatry Residents (Supported by Industry Donors including Arbor Pharmaceuticals and Pfizer))
- National Institute of Mental Health (MH094612)
- The Sörensen Foundation (Postdoctoral Research Fellowship)
- The Health Resources and Services Bureau of Primary Health Care (U30CS22742)
This publication has 34 references indexed in Scilit:
- Family Rejection as a Predictor of Suicide Attempts and Substance Misuse Among Transgender and Gender Nonconforming AdultsLGBT Health, 2016
- Substance use and treatment of substance use disorders in a community sample of transgender adultsDrug and Alcohol Dependence, 2015
- Young Adult Psychological Outcome After Puberty Suppression and Gender ReassignmentPediatrics, 2014
- A conceptual framework for clinical work with transgender and gender nonconforming clients: An adaptation of the Minority Stress Model.Professional Psychology: Research and Practice, 2012
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7International Journal of Transgenderism, 2012
- Screening for serious mental illness in the general population with the K6 screening scale: results from the WHO World Mental Health (WMH) survey initiativeInternational Journal of Methods in Psychiatric Research, 2010
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2009
- A farewell to Bonferroni: the problems of low statistical power and publication biasBehavioral Ecology, 2004
- How can I deal with missing data in my study?Australian and New Zealand Journal of Public Health, 2001
- How can I deal with missing data in my study?Australian and New Zealand Journal of Public Health, 2001